An associate professor with Salk Institute was named one of three winners of the Blavatnik National Awards for Young Scientists, which comes with $250,000 for her pioneering bacteria research.
John Farnam of Receptos has been named as COO of Kura Oncology. He will start in the newly created position July 1.
Calibr, a nonprofit affiliated with Scripps Research, announced a collaboration with pharmaceutical AbbVie built on developing therapies, primarily for cancer, including solid tumors.
The U.S. Food and Drug Administration has approved a plant-derived cannabis medicine, benefitting Carlsbad’s Greenwich Biosciences, the U.S. subsidiary of United Kingdom-based GW Pharmaceuticals.
BIOTECH: It’s Still Low For Medtech Peers; Co. Inks International Deals
This comeback story appears to have legs.
William Welch has resigned as CEO and director of San Diego biotech Trovagene, citing personal reasons. The resignation is effective immediately.
Tandem Diabetes Care won U.S. Food and Drug Administration approval for an automated insulin technology designed to reduce the frequency and duration of low blood sugar events.
La Jolla Institute for Allergy and Immunology has elected three new board members:
A Heron Therapeutics postoperative pain anesthetic hit clinical trial targets in two additional areas, sending the company’s stock soaring.
San Diego-based Crinetics Pharmaceuticals, focused on endocrine-related cancers and endocrine disorders, appointed Alan Krasner as chief medical officer.
Sharp Mary Birch Hospital for Women & Newborns was awarded a $2.9 million grant to lead a multi-hospital, international study on a technique to increase the flow of blood from the umbilical cord into the infant’s circulatory system.
Boston-based Vertex Pharmaceuticals has opened a 170,000-square-foot research facility in San Diego, more than doubling the company’s footprint locally.
MEDICINE: High Volume a Must; Adoption Becoming Norm
In San Diego hospitals, robots are on the rise, judging by splashy marketing and an increase in robotic surgery cases, per data obtained by the San Diego Business Journal.
Damien McDevitt has joined Carlsbad’s Ionis Pharmaceuticals as chief business officer.
PHARMA: Scientist.com Doubles Revenue to $50M
Scientist.com reported $50.27 million in 2017 revenue, a whopping increase from $23.07 million in 2016 and $6 million in 2015.
A new UC San Diego center is targeting an unmet need: parasitic infections hurting poor and underserved communities.
A shareholder of San Diego-based biotech Senomyx is pushing for the company’s chairman to resign, an immediate company sale and a new board seat.
The San Diego/Imperial Chapter of the Alzheimer’s Association awarded a three-year, $175,000 fellowship to a UC San Diego researcher on a quest to determine the earliest indications of Alzheimer’s disease.
PHARMA: They’re Part of Growing Biotech Relationship
In San Diego, the last decade gave rise to biotechs farming out work to contract research organizations, or CROs. It’s an industry increasingly colored by China.
San Diego biotech Metacrine, which is working on drugs for liver, metabolic and gastrointestinal diseases, last week closed a $65 million Series C round.
San Diego biotech Trovagene closed an $18 million public offering on June 12.
A well-known researcher at Salk Institute for Biological Studies resigned on June 11 after an investigation into his conduct.
San Diego-based Vical is terminating its herpes vaccine candidate following not-so-great mid-stage clinical trial results.
HEALTH: Brings Opportunities in Billing, Records and Analytics
ResMed’s acquisition of Healthcarefirst looks to tap into a growing trend: digitally connected devices for those who prefer medical care at home.
MEDICINE: Diversity Is a Must, Both in Patients and Studies
Artemis Institute for Clinical Research helps to advance groundbreaking treatments. A challenge in this line of work: getting people in the door.
A COO/CFO gig at Carlsbad’s Oska Wellness belongs to Bob Ohlweiler, who has held positions with Hewlett-Packard, Kodak, Yahoo!, Razer, and MusicMatch.
Craig Venter is retiring as the CEO of San Diego-based Human Longevity Inc., about five months after reassuming the role.
Net proceeds from Pfenex’s common stock offering amounted to $39.4 million, it was recently announced.
San Diego-based trade group Biocom appointed four new board members. The new members, announced May 31, play major roles in the region’s life sciences ecosystem:
San Diego-based ResMed will acquire HEALTHCAREfirst, which specializes in software for home health and hospice agencies.
Once-ousted CEO Joseph Payne is back leading Arcturus Therapeutics. Even he saw a return as a longshot.
The California Life Sciences Association has a new board member: Jared Watkin, the senior vice president of Diabetes Care at Abbott Laboratories.
Former Arcturus CEO Joseph Payne appears to have prevailed in a fight for control of the company.
PHARMA: Skipping Partnerships Can Build Profits and Skill Sets
Several San Diego biotechs — including Neurocrine and Arena Pharmaceuticals — are bucking the norm by handling drug commercialization themselves.
J. Craig Venter is retiring as the CEO of San Diego-based Human Longevity, Inc., about five months after reassuming the role.
BIOTECH: From Cancer to Concussions, Efforts Change Cost, Course of Treatments
Banyan Biomarkers hit a milestone in February when its blood test for traumatic brain injuries won U.S. Food and Drug Administration approval.
FINANCE: Co. Doesn’t Expect Any Change to U.S. Tax Assessment
San Diego-based ResMed is challenging an Australian Taxation Office assessment saying the company owes $190.1 million.
A proxy fight between Arcturus Therapeutics’ board and former CEO will play out at a newly set June meeting.
San Diego-based Bloom Science, which emerged May 24, is drawing upon gut bacteria to develop medicines.
San Diego biotech Evofem Biosciences, which focuses on women’s sexual and reproductive health, announced a public stock offering on May 22.
San Diego’s AristaMD has hired Adam Darkins, known for his work with the Department of Veterans Affairs, as the company's chief strategy officer.
The Gary and Mary West Emergency Department at UC San Diego Health last week was accredited as a geriatric emergency department, the first such accreditation in California and one of only eight nationally.
San Diego-based Cidara Therapeutics and Rutgers University were awarded a $5.5 million grant to research and further develop an immunotherapy platform.
HEALTH: Drug Treats Seizures; Co. Prepares For Commercialization
A plant-derived cannabis medicine is poised to be the first of its kind to win U.S. Food and Drug Administration approval. A winner of the expected greenlight: Carlsbad’s Greenwich Biosciences.
PHARMA: Co. Transforms After Weight-Loss Flop
Arena Pharmaceuticals’ weight-loss drug flopped a few years ago, signaling a bleak future. That is, if you ignored Arena’s shelved compounds.
Accelerator Life Science Partners, a life science investment and management firm, has opened a San Diego office at The Alexandria at Torrey Pines.
Former film executive Sherry Lansing, who led Paramount and Fox motion picture studios, has been named to The Scripps Research Institute board.
BIOTECH: Acquisition Moves Co. Toward Push-Button Process for Analysis
Illumina bought data processing specialist Edico Genome for $100 million as part of a bid to expand genomics testing in research and health care.
Genomics giant Illumina has purchased Edico Genome, adding a processing platform to Illumina’s portfolio.
San Diego-based MEI Pharma reported on May 14 raising $75 million through a private placement, led by Vivo Capital and CAM Capital.